adcendo Revenue and Competitors
Estimated Revenue & Valuation
- adcendo's estimated annual revenue is currently $18.3M per year.
- adcendo's estimated revenue per employee is $243,880
- adcendo's total funding is $242M.
Employee Data
- adcendo has 75 Employees.
- adcendo grew their employee count by 44% last year.
adcendo's People
| Name | Title | Email/Phone |
|---|
adcendo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is adcendo?
ADCendo ApS seeks to explore novel targets in development of antibody-drug conjugates, to create new anti-cancer medicine for patients with a significant unmet need. The company was founded in 2017 in Copenhagen, as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen. ADCendo ApS is a resident company at Bioinnovation Institute (BII).
keywords:N/A
$242M
Total Funding
75
Number of Employees
$18.3M
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
adcendo News
2022-04-13 - Adcendo presents Data on uPARAP targeting ADCs in ...
The poster presentation highlights the preclinical evaluation of several of Adcendo´s ADC candidates for the treatment of osteosarcoma.
Other Companies in Copenhagen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.5M | 75 | 19% | N/A |
#2 | $7.5M | 76 | 46% | N/A |
#3 | $11M | 76 | 27% | N/A |
#4 | $10.6M | 76 | 375% | N/A |
#5 | $15.8M | 77 | 67% | N/A |